2026-03-31
25
Today, the 15th Annual Conference of Ouryao (Nantong Haimen) was grandly held in Haimen, Nantong, Jiangsu Province. Ouryao enthusiasts, industry experts, and representatives of pharmaceutical enterprises from across the country gathered together to celebrate this annual event.
This year's annual conference focused on in-depth discussions on current pharmaceutical industry policies and regulations, cutting-edge technologies, and future development trends. For the first time, the "Biopharmaceutical Innovation Navigator Award" was established, aiming to recognize benchmark enterprises that have achieved significant breakthroughs in pharmaceutical technology R&D, product innovation, and industrial translation, and have had a profound impact on the development of the industry.
Jiangsu JV Bio-Equipment Co., Ltd. (hereinafter referred to as "JV Bio") successfully won this award with its fully closed-loop localized ecosystem for fluid process equipment—covering everything from process development and equipment manufacturing to engineering implementation. This substantial honor is not only an authoritative recognition of JV Bio's past efforts but also a heartfelt expectation for our future journey.
JV Bio stood out among numerous outstanding peers thanks to our unwavering commitment to the original aspiration of "achieving a fully closed-loop localization of fluid process equipment—from process development and equipment manufacturing to engineering implementation."
Leveraging our proprietary fluid process technology platform, JV Bio has built a comprehensive product portfolio covering formulation systems, bioreactors, and biological fermentation systems, precisely targeting key pharmaceutical manufacturing scenarios such as antibody drugs, vaccines, and sterile injections.
In terms of technological innovation and project delivery, JV Bio has successfully completed multiple industry benchmark projects with its solid technical capabilities:
✅ Provided a peptide purification formulation system for one of the very few global peptide drug companies with annual production capacity at the ton-level
✅ Supplied a stainless steel pipe-and-tank system for EPO / long-acting EPO production to one of China's largest antibody drug manufacturing bases
✅ Delivered a formulation system for diploid cell rabies vaccine bulk production to China's first human rabies vaccine manufacturer
✅ Provided a sterile liposome formulation system to a domestic leader in nucleic acid drug delivery technologies and complex formulations
✅ Supplied a paclitaxel albumin liposome formulation system to a biopharmaceutical innovator focused on photodynamic therapy drugs
These cases are powerful proof of JV Bio's ability to break through critical process equipment technological bottlenecks and empower the development of the biopharmaceutical industry.
"Navigator" is not only an honor, but also a weighty responsibility. At present, the biopharmaceutical industry is undergoing an unprecedented wave of transformation, ushering in a new landscape of development. JV Bio will take this award as a new starting point, firmly embrace the mission of being a "navigator," and actively contribute our professional and reliable "JV Bio strength" as we walk side by side with the industry to co-create the future.
This award is a splendid footnote to the journey we have completed, and even more so, a resounding bugle call for the journey ahead. JV Bio will take this as encouragement, live up to the honor of "Navigator," and with firmer strides, sail forward through the innovative blue ocean of biopharmaceuticals, repaying every expectation and trust with even more breakthrough achievements!
